CN1190235C - 复方羊胎素保健食品系列制备方法 - Google Patents
复方羊胎素保健食品系列制备方法 Download PDFInfo
- Publication number
- CN1190235C CN1190235C CNB02101969XA CN02101969A CN1190235C CN 1190235 C CN1190235 C CN 1190235C CN B02101969X A CNB02101969X A CN B02101969XA CN 02101969 A CN02101969 A CN 02101969A CN 1190235 C CN1190235 C CN 1190235C
- Authority
- CN
- China
- Prior art keywords
- powder
- caprae seu
- seu ovis
- lyophilized powder
- royal jelly
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 241001494479 Pecora Species 0.000 title claims abstract description 41
- 239000000284 extract Substances 0.000 title claims abstract description 34
- 210000002826 placenta Anatomy 0.000 title claims abstract description 29
- 150000001875 compounds Chemical class 0.000 title claims abstract description 22
- 235000013305 food Nutrition 0.000 title claims abstract description 13
- 238000004519 manufacturing process Methods 0.000 title claims description 18
- 238000000034 method Methods 0.000 claims abstract description 34
- 241000222336 Ganoderma Species 0.000 claims abstract description 31
- 229940109850 royal jelly Drugs 0.000 claims abstract description 30
- 229920001542 oligosaccharide Polymers 0.000 claims abstract description 24
- 150000002482 oligosaccharides Chemical class 0.000 claims abstract description 23
- 239000002775 capsule Substances 0.000 claims abstract description 15
- 239000007788 liquid Substances 0.000 claims abstract description 10
- 238000010298 pulverizing process Methods 0.000 claims abstract description 9
- 239000000843 powder Substances 0.000 claims description 49
- 241000283898 Ovis Species 0.000 claims description 39
- 239000008176 lyophilized powder Substances 0.000 claims description 37
- 235000005956 Cosmos caudatus Nutrition 0.000 claims description 27
- 244000293323 Cosmos caudatus Species 0.000 claims description 27
- 239000000203 mixture Substances 0.000 claims description 25
- 230000003169 placental effect Effects 0.000 claims description 22
- 230000008569 process Effects 0.000 claims description 22
- 239000008187 granular material Substances 0.000 claims description 21
- 239000002994 raw material Substances 0.000 claims description 21
- 239000000796 flavoring agent Substances 0.000 claims description 15
- 238000001035 drying Methods 0.000 claims description 14
- 238000007710 freezing Methods 0.000 claims description 12
- 210000001161 mammalian embryo Anatomy 0.000 claims description 12
- 235000019687 Lamb Nutrition 0.000 claims description 11
- 238000012545 processing Methods 0.000 claims description 11
- 239000007901 soft capsule Substances 0.000 claims description 10
- 238000004321 preservation Methods 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 7
- 108091005804 Peptidases Proteins 0.000 claims description 6
- 239000004365 Protease Substances 0.000 claims description 6
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 6
- 238000013019 agitation Methods 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 235000013355 food flavoring agent Nutrition 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 4
- 230000033228 biological regulation Effects 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 230000006870 function Effects 0.000 abstract description 13
- 230000003796 beauty Effects 0.000 abstract description 7
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract description 5
- 239000011575 calcium Substances 0.000 abstract description 5
- 229910052791 calcium Inorganic materials 0.000 abstract description 5
- 238000005516 engineering process Methods 0.000 abstract description 4
- 239000003053 toxin Substances 0.000 abstract description 4
- 231100000765 toxin Toxicity 0.000 abstract description 4
- 210000002784 stomach Anatomy 0.000 abstract description 3
- 230000003712 anti-aging effect Effects 0.000 abstract description 2
- 210000003734 kidney Anatomy 0.000 abstract description 2
- 239000003112 inhibitor Substances 0.000 abstract 1
- 235000015097 nutrients Nutrition 0.000 abstract 1
- 230000003647 oxidation Effects 0.000 abstract 1
- 238000007254 oxidation reaction Methods 0.000 abstract 1
- 238000005057 refrigeration Methods 0.000 abstract 1
- 238000005728 strengthening Methods 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 230000002936 tranquilizing effect Effects 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 description 19
- 230000000694 effects Effects 0.000 description 16
- 235000019634 flavors Nutrition 0.000 description 10
- 239000003795 chemical substances by application Substances 0.000 description 8
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 7
- 102000053602 DNA Human genes 0.000 description 6
- 108020004414 DNA Proteins 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- 229940088597 hormone Drugs 0.000 description 6
- 239000005556 hormone Substances 0.000 description 6
- 235000016709 nutrition Nutrition 0.000 description 6
- 230000035764 nutrition Effects 0.000 description 6
- 150000001413 amino acids Chemical class 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- 230000000259 anti-tumor effect Effects 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 102000016942 Elastin Human genes 0.000 description 2
- 108010014258 Elastin Proteins 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- 102000004316 Oxidoreductases Human genes 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 239000007963 capsule composition Substances 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 229920002549 elastin Polymers 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 230000007661 gastrointestinal function Effects 0.000 description 2
- 230000003054 hormonal effect Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000006041 probiotic Substances 0.000 description 2
- 235000018291 probiotics Nutrition 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 229920002477 rna polymer Polymers 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000186016 Bifidobacterium bifidum Species 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 102000003914 Cholinesterases Human genes 0.000 description 1
- 108090000322 Cholinesterases Proteins 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241001633942 Dais Species 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 229940123457 Free radical scavenger Drugs 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229940072049 amyl acetate Drugs 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- PGMYKACGEOXYJE-UHFFFAOYSA-N anhydrous amyl acetate Natural products CCCCCOC(C)=O PGMYKACGEOXYJE-UHFFFAOYSA-N 0.000 description 1
- 230000002605 anti-dotal effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000004098 cellular respiration Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940048961 cholinesterase Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000013020 final formulation Substances 0.000 description 1
- 230000004992 fission Effects 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- MNWFXJYAOYHMED-UHFFFAOYSA-M heptanoate Chemical compound CCCCCCC([O-])=O MNWFXJYAOYHMED-UHFFFAOYSA-M 0.000 description 1
- 150000002402 hexoses Chemical class 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 210000003016 hypothalamus Anatomy 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Substances N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000001235 sensitizing effect Effects 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- -1 steroid compound Chemical class 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- CEIZFXOZIQNICU-UHFFFAOYSA-N tenuazonic acid Chemical compound CCC(C)C1NC(=O)C(C(C)=O)=C1O CEIZFXOZIQNICU-UHFFFAOYSA-N 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明涉及一种复方羊胎素保健食品系列制备方法,它由珍珠、灵芝、羊胎、蜂王浆、低聚糖、VA、VC、VE等组成。经低温冷冻干燥粉碎或酶解技术加工的羊胎和王浆能保持其全部活性营养成份;加入誉为美容瑰宝的珍珠和灵芝及双歧因子、VA、VC、VE等抗衰老、抗氧化剂后,再经现代高科技工艺加工成系列胶囊或口服液等产品;其数十种高效活性美容养颜成份,不光对羊胎素具有强力的协同作用;还具有补钙强肾、排毒养胃和安神益寿的神奇作用;是新一代以内养外的美容珍品。
Description
本发明属于保健食品领域,具体涉及一种复方羊胎素保健食品系列制备方法。
目前国内外保健食品市场上,开发出的羊胎素单一制剂比较多见。但因缺少多方面的有效成份,使其功能作用受到一定的限制,而且一般都没有突出具有东方特色的配方优势。
本发明的目的在于提供一种汇聚东西方美容养颜功能优势的中西合璧的新一代复方羊胎素的配方和工艺。它既能保留羊胎素自身美容的功效,又因添加了具有更强有力的协同美容作用;还同时具有补钙强身,排毒养胃和安神益寿的多方面的显著功效;因此比单方更能起到强有力的营养保健作用。
本发明的羊胎精华素是由良种羊的羊胎(含母仔胎盘和胚胎、胎羔),经低温冷冻干燥粉碎处理后,保留其羊胎的全部活性物质,它含有荷尔蒙原激素、脱氧核糖核酸、弹性蛋白素、蛋白胶原素等二十余种营养原素及十七种氨基酸类营养成份等,因为羊胎的胚胎活细胞具有极高的生物活性,它可调节人的内分泌系统和免疫机能,其荷尔蒙的激素,能刺激人体的下丘脑细胞均衡分泌自身激素,促进人体各种机能自律调节,使人保持年轻的状态。DNA是细胞复制、裂变、增加不可缺少的生物活性成份,它能促进新细胞的生长,弹性蛋白质是合成皮肤弹性纤维的重要动力元素,能有效强化组织纤维,改善皮肤弹性,故可达到活化人体各组织系统,并通过荷尔蒙均衡分泌,能调理增强体质,保持脸色红润,皮肤细嫩,毛孔细小,乳房坚挺,性敏感区感觉增强,淡化内分泌失调引起的色斑增多,记忆力减退等衰老症状,促进脂肪代谢,呈现年轻神采,并且产生强大的补益的功能,使无论男女人群均可充分获益,起到美容养颜的有效作用。
本发明只因配方中添加了被誉为东方美容瑰宝的珍珠粉,从而大大增加了它们的协同作用。因为珍珠含有人体必需的多种氨基酸及铁、镁、锌、钠等多种微量元素,特别富含80-90%以上的碳酸钙的成份,增强体质、延缓衰老。我国历代宫廷贵族及近代名人奉珍珠为常葆容颜之上品。历代名医一致以为其有安神定惊、明目消翳、解毒生肌作用,适用于:神经衰弱、失眠、咽喉肿痛、胃及十二指肠溃疡和外治水火烫伤、创口收敛和美颜嫩肤等功效。而目前运用超细或水解珍珠的高科技加工工艺,更提高了其有效成份的提取和吸收,从而产生更显著的美容效果来。
本发明配方中还添加了被誉为东方仙草的灵芝。而根据明代李自珍在《左草纲目》中述称:灵芝能“主耳聋、利关节、保神、益心气、补中、增智慧、益精气、坚筋骨、好颜色。”“疗虚劳、治痔、久服能轻身、不老延年。”灵芝及孢子粉富含蛋白质及18种氨基酸、多糖、多肽、灵芝酸、腺苷、总碱等成份,药理表明具有抗肿瘤及抗衰老作用,能明显增强巨噬细胞的吞噬功能,调节机体免疫力,并对神经中枢有镇静、镇痛作用,还能减轻放射线引起的毒性反应等。因添加了经特别加工过的超细灵芝粉,使常食者更加青春常驻,容颜不老,起到显著的协同作用。
本发明配方中还因添加了经高科技冷冻干燥加工后的新鲜蜂王浆,使该产品更显锦上添花。因为,蜂王浆是一种营养价值非常丰富的纯天然补品。它含蛋白质12%、总脂类6%、糖类13%、矿物质及各种维生素1%。蛋白质中又含许多种多呔(如类胰岛素呔等)和各种游离氨基酸,其中有维持人体正常生长发育所必需的各种氨基酸,还含有核糖核酸(RNA)和脱氧核糖核酸(DNA)。蜂王浆中至少有20多种游离的脂肪酸,含有7-9种固醇类化合物,这类物质是激素的组成成份。它还含有乙酰胆碱、神经鞘磷脂、磷脂酰乙醇胺、肾上激素、胆碱脂酶、淀粉酶、葡萄糖氧化酶、抗坏血酸氧化酶等多种酶类及钠、钾、钙、镁、铁、铜、锌等矿物元素等。。蜂王浆经科学家实验证实是一种能促进增强人体机能,延长人体寿命并对机体的多种功能有调节作用,对多种疾病(包括肿瘤)有预防和辅助治疗作用的天然补品。
本发明还在配方中加入低聚糖成份,目的是起到有益于人体肠道内有益菌一双歧杆菌的生存繁殖等。因为,肠胃消化功能是人的后天之本,人体的肠胃功能减弱,往往是因有益菌生存环境的破坏所造成的,故加入被誉双歧因子的低聚糖,可帮助人体吃得好,排得顺,达到及时吸收获得各种营养和排出各种毒素的目的,促使人体进入良性循环的健康美丽的状态。这就是加入低聚糖后,更能起到特殊的协同排毒养颜的作用。
最后配方中还加入了VA、VC、VE三种维生素。因为人体的皮肤的正常生理功能的进行离不开它们的积极配合与参与。因此,常服维生素A醋酸脂,可保护人的眼睛和促进骨骼、牙齿和机体的正常生长,还能增强生殖能力和消除自由基的抗氧化作用。对保护皮肤和抗肿瘤都有一定作用。因此,非常需要得到强化式的多种维生素补充。而维生素C又名抗坏血酸,又是一种十分重要的活性成分。人体由于缺乏由六碳糖合成VC所必需的古洛糖酸内脂氧化酶,因此必须在食物中摄取。维生素C能促进胶原的生物合成,有利于组织伤口的愈合;它能促进骨骼的和牙齿的生长,增强气细血管璧强度,避免骨骼和牙齿周围出现渗血现象;它能促进酪氨酸和色氨酸的代谢,加速蛋白或肽类的脱氨基代谢作用;它能影响脂肪和类脂的代谢;它能改善对铁、钙和叶酸的利用;它可起到清除人体自由基的作用;它能增强机体对外界环境的应激能力,具有抗肿瘤和抗病毒、抗氧化的显著作用。而维生素E(又名生育酚)是一种强效的自由基清除剂,能保护机体细胞膜及生命大分子免遭自由基的攻击,能保持血红细胞的完整性,调节体内化合物的合成,并能促进细胞呼吸,保护肺组织免遭空气污染的作用,有延缓衰老,防治心血管疾病和抑制肿瘤的良好作用。
本发明因由八味优良的美容养颜原料的强强组合,故有以下八方面的优点:
(1)因在单一的羊胎素的基础上加入了超细珍珠粉,强化了该产品的美容和补钙安神作用。
(2)因在单一的羊胎素的基础上加入了超细灵芝粉,强化了该产品的养颜和增强人体免疫能力及抗衰老的功能。
(3)因在单一的羊胎素的基础上加入了能调节肠胃功能,增殖双歧杆菌的双歧因子—低聚糖;故促使人体营养吸收功能,并确保肠道通畅,起到即时排尽体内毒素的作用;因此,对羊胎素的美容养颜功能有强大的协同作用。
(4)更因添加了维生素A、C、E,确保了这三种重要的基本营养元素在保证人体健康,特别是对美容养颜、抗衰老、抗氧化方面的重大作用,也是对单味羊胎素功效不足部分的有力补充和强化,必将起到更加显著的协同作用。
(5)最后还因添加了蜂王浆的强力有效成份,使本产品的显效期大大缩短,一般只要试服该产品1-2天,即可明显感觉到疲劳程度的减轻,食欲的增加和睡眠质量的改善及人体活力的增强,使食用者更加信任该产品的疗效。
(6)本发明对鲜羊胎及鲜蜂王浆原料,都采用低温冷冻干燥粉碎和低温酶解的高科技工艺加工,能够达到保留其全部活性成份,对珍珠、灵芝又采用超细粉碎工艺,确保达到其更利于人体吸收,起到更好的保健作用。
(7)本发明的配方,充分参照了中西方在美容养颜需求中的传统习惯方面的差异和各自的优势;运用中西合璧的组方原理,使东方的灵芝仙草和美容瑰宝珍珠、蜂王浆与西方传统美容原料羊胎及低聚糖和VA、VC、VE等完美地结合,更能达到既显著又强大的协同作用;使本配方的美容保健效果,更能得到最理想化的实现。
(8)本发明还可对以上八味原料作必要的系列加减组方,以适应不同人群的特殊需要和起到简化生产工艺和降低生产成本的作用。
本发明的组方主要是由羊胎素(含母仔胎盘及胚胎、胎羔)、珍珠、灵芝、蜂王浆、低聚糖、VA、VC、VE等组成。主要有以下几种系列配方:
(1)八合一剂型:羊胎素加入珍珠粉,灵芝粉、蜂王浆、低聚糖及VA、VC、VE八味可分别制成胶囊、软胶囊、口服液;胶囊剂型粒重0.2-0.4g中净含原料成份的比例分别为:羊胎素冻干粉60%、珍珠粉、灵芝粉、蜂王浆冻干粉、低聚糖各10%,再加VA200-400RE、VC50-100mg、VE5-10mg;而软胶囊剂型粒重0.3-0.6g所含原料实际干重为::羊胎素冻干颗粒0.18-0.36g、王浆冻干粉0.03-0.06g、珍珠粉0.03-0.06g、灵芝粉0.03-0.06g、低聚糖0.03-0.06g、VA200-400RE、VC50-100mg、VE5-10mg及含少许水份;而口服液每20cc-500cc中所含原料成份分别为:羊胎素冻干颗粒0.42-10.5g、王浆冻干粉0.18-4.5g、水溶性珍珠粉1.4-35g、灵芝粉0.06-1.5g、低聚糖5-125g及VA400-1000RE、VC100-2500mg、VE10-250mg;其余为调味剂和水。
(2)七合一剂I型:将(1)剂型原八味原料中减去低聚糖成份,其中胶囊与软胶囊剂型的每粒蜂王浆冻干粉的比例增为20%,其余方面与(1)相同。
(3)七合一剂II型:将(1)剂型原八味原料中减去灵芝粉成份,其中胶囊与软胶囊剂型的每粒羊胎素冻干粉的比例增为70%,其余方面与(1)相同。
(4)六合一剂I型:将(1)剂型原八味原料中减去低聚糖和灵芝粉二种成份,其中胶囊与软胶囊剂型的每粒王浆冻干粉的比例增为20%,把珍珠粉的比例也增加到20%,其余方面仍与(1)相同。
(5)六合一剂II型:将(1)剂型原八味原料中减去VA、VC成份,其余方面仍与(1)相同。
(6)五合一剂I型:将(4)剂型原六味原料中减去VA成份,其余方面仍与(4)相同。
(7)五合一剂II型:将(1)剂型原八味原料中减去VA、VC、VE三种维生素成份,其余方面仍与(1)相同。
(8)四合一剂I型:将(6)剂型原五味原料中减去VA成份,其余方面仍与(6)相同。
(9)四合一剂II型:将(2剂型原七味原料中减去VA、VC、VE三种成份,其余方面仍与(2)相同。
(10)三合一剂型:将(8)剂型原四味原料中再减去VA成份,其余方面仍与(8)相同。其服法:羊胎素胶囊与软胶囊剂型,每粒净含0.2-0.6g,口服每日二次,每次1-2粒,饭前半小时服用。口服液剂型:每瓶含20cc-500cc,口服每日一次,每次20cc-40cc,临睡前半小时服用。
现将三种剂型的生产工艺流程表述如下:
(一)复方胶囊剂生产工艺流程:鲜羊胎-洗净、滤干、速冻、粗粉碎-将冻羊胎颗粒与鲜王浆分别再经低温冷冻干燥、细粉碎处理后冷藏-先按比例取羊胎冻干粉和王浆冻干粉相混合,再加入一定比例的超细珍珠粉、超细灵芝粉、低聚糖、VA、VC、VE中的一种或数种-经混合搅拌-填充胶囊-分装-灭菌-检验-标签-包装-成品。
(二)复方软胶囊剂生产工艺流程:鲜羊胎-洗净、滤干、速冻、粗粉碎-将冻羊胎颗粒与鲜王浆分别再经低温冷冻干燥、细粉碎处理后冷藏-先按比例取羊胎冻干颗粒,经常规低温酶解法处理-再按比例加入王浆冻干粉、超细珍珠粉、超细灵芝粉、低聚糖、VA、VC、VE中的一种或数种-经搅拌配制成稠糊状混合原料-填充成软胶囊-分装-灭菌-检验-标签-包装-成品。
(三)复方口服液剂生产工艺流程:鲜羊胎-洗净、滤干、速冻、粗粉碎-将冻羊胎颗粒与鲜王浆分别经低温冷冻干燥处理后冷藏-先按比例取羊胎冻干颗粒经低温酶解法处理-经搅拌过滤-按比例加入鲜王浆冻干粉、水溶性珍珠粉、超细灵芝粉、低聚糖粉、VA、VC、VE中的一种或数种及适量调味添加剂与蒸馏水-再次经搅拌过滤-灌封-灭菌-检验-标签-包装-成品。
现具体介绍多种制备分法如下:
1、一种复方羊胎素保健食品系列制备方法,它的复方胶囊生产工艺流程如下:鲜羊胎含母仔胎盘和胚胎、胎羔,经洗净、滤干、速冻、粗粉碎后,再将鲜羊胎颗粒和鲜王浆分别经低温冷冻干燥和细粉碎处理后,分别制成冻干粉并各自冷藏;再将80-100目羊胎冻干粉60%、蜂王浆冻干粉10%、200目珍珠超细粉10%、200目灵芝超细粉10%和低聚糖10%,混合搅拌后,填充入胶囊。
2、一种复方羊胎素保健食品系列制备方法,在于它的复方软胶囊生产工艺流程如下:鲜羊胎含母仔胎盘和胚胎、胎羔,经洗净、滤干、速冻、粗粉碎后,再将鲜羊胎颗粒和鲜王浆分别经低温冷冻干燥和细粉碎处理后,分别制成冻干粉并各自冷藏;再取羊胎冻干粉规定比例的量、采用常规低温蛋白酶水解法制取羊胎素水解液;再分别各按规定比例加入蜂王浆冻干粉、200目珍珠超细粉、200目灵芝超细粉和低聚糖的量,混合搅拌后,配制成稠糊状混合原料并将PH值调整到2.5-7.5之间,最后填充入软胶囊;制成每粒净重为0.3g-0.6g,其中含原料的成份比例分别为:羊胎素冻干颗粒0.18g-0.36g、王浆冻干粉0.03g-0.06g、200目珍珠超细粉0.03g-0.06g、200目灵芝超细粉0.03g-0.06g、低聚糖0.03g-0.06g。
3、一种复方羊胎素保健食品系列制备方法,它的复方口服液的生产工艺流程如下:它将鲜羊胎含母仔胎盘和胚胎、胎羔,经洗净、滤干、速冻、粗粉碎后,再将鲜羊胎颗粒和鲜王浆分别经低温冷冻干燥和细粉碎处理后,分别制成冻干粉并各自冷藏;再以每20cc-500cc口服液中含有羊胎冻干粉颗粒0.42-10.5g的比例,采用常规低温蛋白酶水解法制取羊胎素水解液;经搅拌过滤后,再分别按比例加入鲜王浆冻干粉0.18-4.5g、灵芝粉0.06-1.5g、水溶性珍珠粉1.4-35g和低聚糖5-125g;其余为调味剂和水。
现将第一实施例的最佳胶囊剂工艺流程与配方作进一步详述:七合一胶囊剂型:精选10-16周鲜羊胎(含母仔胎盘和胚胎、胎羔)-经洗净,滤干、速冻、粗粉碎-将鲜羊胎颗粒和鲜王浆分别经低温冷冻干燥,细粉碎处理后冷藏-80-100目羊胎冻干粉60%、蜂王浆冻干粉20%、200目珍珠超细粉10%、200目灵芝超细粉10%及VA、VC、VE各适量-混合搅拌-填充入胶囊-分装-灭菌-检验-标签-包装-成品。每粒净含量为0.2-0.4g,其中含原料成份分别为:100目羊胎素冻干粉0.12-0.24g、王浆冻干粉0.04-0.08g、200目珍珠超细粉0.02-0.04g、200目灵芝超细粉0.02-0.04g、VA200-400RE、VC50-100mg、VE5-10mg。
现将第二实施例的最佳软胶囊剂工艺流程与配方作进一步详述:七合一软胶囊剂型:精选10-16周鲜羊胎(含母仔胎盘和胚胎、胎羔)-经洗净、滤干、速冻、粗粉碎-将鲜羊胎颗粒和鲜王浆分别经低温冷冻干燥处理后冷藏-取羊胎冻干粉60%,采用常规低温蛋白酶水解法制取羊胎素水解液-分别按比例加入蜂王浆冻干粉20%、200目珍珠超细粉10%、200目灵芝超细粉10%及VA、VC、VE各适量-经搅拌配制成稠糊状混合原料并将PH值调整到2.5-7.5之间-填充成软胶囊-分装-灭菌-检验-标签-包装-成品。每粒净含量为0.3-0.6g,其中含原料成份分别为:羊胎素冻干颗粒0.18-0.36g、王浆冻干粉0.06-0.12g,200目珍珠超细粉0.03-0.06g、200目灵芝超细粉0.03-0.06g、VA200-400RE、VC50-100mg、VE5-10mg;其余为少量水份系。
现将第三实施例的最佳口服液剂工艺流程与配方作进一步详述:七合一剂口服液型:精选10-16周鲜羊胎(含母仔胎盘和胚胎、胎羔)-经洗净、滤干、速冻、粗粉碎-将鲜羊胎颗粒和鲜王浆分别经低温冷冻干燥处理后冷藏-取羊胎冻干粉70%,采用常规低温蛋白酶水解法制取羊胎素水解液-经搅拌过滤后-再分别加入鲜蜂王浆冻干粉30%、水溶性珍珠超细粉、低聚糖、VA、VC、VE及调味剂和蒸馏水各适量-再次搅拌过滤-取透明原液灌封-辐照灭菌-检验-标签-包装-成品。每瓶净装20cc-200cc,其中所含原料成份的量分别为:羊胎素0.42-4.2g、王浆0.18-1.8g、水溶性珍珠粉1.40-14g、麦芽低聚糖粉5-50g、VA400-4000RE、VC100-1000mg、VE10-100mg;其余都为调味剂和蒸馏水。
本技术具体实例可根据成份的加减,变化出许多相似的配方和工艺流程方案来,只要跟文中所举(1)-(10)种配方剂型相同或相似,无论采用以上任何一种工艺流程方法加工,都属于本系列技术保护范围。
Claims (3)
1、一种复方羊胎素保健食品系列制备方法,其特征在于它的复方胶囊生产工艺流程如下:鲜羊胎含母仔胎盘和胚胎、胎羔,经洗净、滤干、速冻、粗粉碎后,再将鲜羊胎颗粒和鲜王浆分别经低温冷冻干燥和细粉碎处理后,分别制成冻干粉并各自冷藏;再将80-100目羊胎冻干粉60%、蜂王浆冻干粉10%、200目珍珠超细粉10%、200目灵芝超细粉10%和低聚糖10%,混合搅拌后,填充入胶囊。
2、一种复方羊胎素保健食品系列制备方法,其特征在于它的复方软胶囊生产工艺流程如下:鲜羊胎含母仔胎盘和胚胎、胎羔,经洗净、滤干、速冻、粗粉碎后,再将鲜羊胎颗粒和鲜王浆分别经低温冷冻干燥和细粉碎处理后,分别制成冻干粉并各自冷藏;再取羊胎冻干粉规定比例的量、采用常规低温蛋白酶水解法制取羊胎素水解液;再分别各按规定比例加入蜂王浆冻干粉、200目珍珠超细粉、200目灵芝超细粉和低聚糖的量,混合搅拌后,配制成稠糊状混合原料并将PH值调整到2.5-7.5之间,最后填充入软胶囊;制成每粒净重为0.3g-0.6g,其中含原料的成份比例分别为:羊胎素冻干颗粒0.18g-0.36g、王浆冻干粉0.03g-0.06g、200目珍珠超细粉0.03g-0.06g、200目灵芝超细粉0.03g-0.06g、低聚糖0.03g-0.06g。
3、一种复方羊胎素保健食品系列制备方法,其特征在于它的复方口服液的生产工艺流程如下:它将鲜羊胎含母仔胎盘和胚胎、胎羔,经洗净、滤干、速冻、粗粉碎后,再将鲜羊胎颗粒和鲜王浆分别经低温冷冻干燥和细粉碎处理后,分别制成冻干粉并各自冷藏;再以每20cc-500cc口服液中含有羊胎冻干粉颗粒0.42-10.5g的比例,采用常规低温蛋白酶水解法制取羊胎素水解液;经搅拌过滤后,再分别按比例加入鲜王浆冻干粉0.18-4.5g、灵芝粉0.06-1.5g、水溶性珍珠粉1.4-35g和低聚糖5-125g;其余为调味剂和水。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB02101969XA CN1190235C (zh) | 2002-01-19 | 2002-01-19 | 复方羊胎素保健食品系列制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB02101969XA CN1190235C (zh) | 2002-01-19 | 2002-01-19 | 复方羊胎素保健食品系列制备方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1363393A CN1363393A (zh) | 2002-08-14 |
| CN1190235C true CN1190235C (zh) | 2005-02-23 |
Family
ID=4739638
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB02101969XA Expired - Fee Related CN1190235C (zh) | 2002-01-19 | 2002-01-19 | 复方羊胎素保健食品系列制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1190235C (zh) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5202827B2 (ja) * | 2006-08-04 | 2013-06-05 | 雪印メグミルク株式会社 | 感染予防剤 |
-
2002
- 2002-01-19 CN CNB02101969XA patent/CN1190235C/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1363393A (zh) | 2002-08-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104643250B (zh) | 一种可双向调节体重改善亚健康的固体饮料 | |
| CN102763795B (zh) | 一种益母红糖及其制备方法 | |
| CN102987379A (zh) | 一种含枸杞、菊花、胶原蛋白、柠檬、水苏糖的组合物 | |
| CN103710237B (zh) | 一种蜂产品酒及其制备方法 | |
| CN106923130A (zh) | 含西红花的固体饮料、其制备方法及应用 | |
| CN101816427B (zh) | 黑木耳、蜂王浆、大鲵细粉混合物及其制备方法 | |
| CN103976202A (zh) | 一种可食用胶原蛋白果冻及其制备方法 | |
| CN103461817B (zh) | 一种含木鱼石粉的营养馒头 | |
| CN111184214A (zh) | 酵素胶原蛋白杂粮果蔬即食代餐粥及其制作方法 | |
| CN101991110B (zh) | 野生灵芝系列食品 | |
| CN1190235C (zh) | 复方羊胎素保健食品系列制备方法 | |
| CN105176773A (zh) | 一种调节血糖的南瓜酒及其制作方法 | |
| CN100506085C (zh) | 一种能够提高产妇免疫力的红糖保健品 | |
| CN100479671C (zh) | 一种复方微米松花魔芋露减肥降糖酸奶制备方法 | |
| CN102511882A (zh) | 一种有助于改善生长发育的红枣浓浆 | |
| CN100350846C (zh) | 一种微米糖参马桃花鹿补肾消疲酸奶制备方法 | |
| CN1219461C (zh) | 复方糖参肉灵芝王保健食品的制备方法 | |
| CN110089751A (zh) | 肠排保健品 | |
| CN104187264B (zh) | 一种提高人体免疫力的营养组合物及其制备方法 | |
| KR20160057183A (ko) | 발효 오신채 추출물을 함유하는 화장료 조성물 | |
| CN1102396C (zh) | 复方组合型美灵脂花保健食品的系列制备方法 | |
| CN108142929A (zh) | 一种含蚕蛹健康营养食品 | |
| CN108835264A (zh) | 高级藜麦谷粒营养奶 | |
| CN1323593C (zh) | 一种微米参鹿珍珠松花粉壮阳消疲补钙奶液制备方法 | |
| CN100377663C (zh) | 一种微米参鹿珍珠松花粉壮阳消疲补钙口服液制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |